By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Centene Corporation

Centene Corporation (0HVB.L)

LSE Currency in USD
$29.42
-$0.47
-1.58%
Last Update: 17 Jul 2025, 15:34
$14.64B
Market Cap
3.54
P/E Ratio (TTM)
Forward Dividend Yield
$29.25 - $81.42
52 Week Range

0HVB.L Stock Price Chart

Explore Centene Corporation interactive price chart. Choose custom timeframes to analyze 0HVB.L price movements and trends.

There is nothing to show.

0HVB.L Company Profile

Discover essential business fundamentals and corporate details for Centene Corporation (0HVB.L) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Equipment & Services

IPO Date

29 Jan 2018

Employees

60.40K

CEO

Sarah M. London

Description

Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions and limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members. The company's Specialty Services segment provides pharmacy benefits management services; nurse advice line and after-hours support services; vision and dental services, as well as staffing services to correctional systems and other government agencies; and services to Military Health System eligible beneficiaries. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.

0HVB.L Financial Timeline

Browse a chronological timeline of Centene Corporation corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 23 Apr 2026

Upcoming earnings on 2 Feb 2026

Upcoming earnings on 23 Oct 2025

Upcoming earnings on 24 Jul 2025

Revenue estimate is $44.71B.

Earnings released on 25 Apr 2025

EPS came in at $2.63 surpassing the estimated $2.52 by +4.37%, while revenue for the quarter reached $46.62B, beating expectations by +8.58%.

Earnings released on 4 Feb 2025

EPS came in at $0.56 surpassing the estimated $0.49 by +14.26%, while revenue for the quarter reached $40.81B, beating expectations by +3.78%.

Earnings released on 25 Oct 2024

EPS came in at $1.36 surpassing the estimated $1.35 by +0.74%, while revenue for the quarter reached $42.02B, beating expectations by +10.79%.

Earnings released on 26 Jul 2024

EPS came in at $2.16 surpassing the estimated $2.12 by +1.89%, while revenue for the quarter reached $36.43B, missing expectations by -1.07%.

Earnings released on 26 Apr 2024

EPS came in at $2.16 surpassing the estimated $2.06 by +4.85%, while revenue for the quarter reached $40.41B, beating expectations by +10.91%.

Earnings released on 12 Mar 2024

EPS came in at $0.08 falling short of the estimated $0.42 by -80.07%, while revenue for the quarter reached $39.46B, beating expectations by +9.17%.

Earnings released on 24 Oct 2023

EPS came in at $0.87 falling short of the estimated $1.55 by -44.13%, while revenue for the quarter reached $38.04B, beating expectations by +4.97%.

Earnings released on 28 Jul 2023

EPS came in at $1.92 falling short of the estimated $2.05 by -6.34%, while revenue for the quarter reached $37.61B, beating expectations by +2.88%.

Earnings released on 25 Apr 2023

EPS came in at $2.04 surpassing the estimated $2.00 by +2.00%, while revenue for the quarter reached $38.89B, beating expectations by +7.62%.

Earnings released on 7 Feb 2023

EPS came in at -$0.38 falling short of the estimated $0.82 by -146.50%, while revenue for the quarter reached $35.56B, beating expectations by +0.47%.

Earnings released on 30 Sept 2022

EPS came in at $1.27 surpassing the estimated $1.23 by +3.25%, while revenue for the quarter reached $35.87B, beating expectations by +1.02%.

Earnings released on 30 Jun 2022

EPS came in at -$0.29 falling short of the estimated $1.60 by -118.42%, while revenue for the quarter reached $35.94B, beating expectations by +1.07%.

Earnings released on 31 Mar 2022

EPS came in at $1.44 falling short of the estimated $1.68 by -14.29%, while revenue for the quarter reached $37.19B, beating expectations by +7.72%.

Dividend declared on 15 Mar 2022

A dividend of $0.29 per share was announced, adjusted to $0.29.

Earnings released on 31 Dec 2021

EPS came in at $1.01 surpassing the estimated $0.98 by +3.48%, while revenue for the quarter reached $32.57B, beating expectations by +0.22%.

Earnings released on 26 Oct 2021

EPS came in at -$0.92, while revenue for the quarter reached $31.03B.

Earnings released on 30 Sept 2021

EPS came in at $0.99, while revenue for the quarter reached $32.41B.

Earnings released on 31 Mar 2021

EPS came in at $1.19, while revenue for the quarter reached $29.98B.

Earnings released on 31 Dec 2020

EPS came in at -$0.02, while revenue for the quarter reached $26.55B.

Earnings released on 30 Sept 2020

EPS came in at $0.97, while revenue for the quarter reached $27.55B.

0HVB.L Stock Performance

Access detailed 0HVB.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

There is nothing to show.
0HVB.L
Company Name
Exchange
Market Currency
Report Currency
Price
Price Change
Percentage Change
50-Day Average Price
200-Day Average Price
Trading Volume
Market Capitalization
0HVB.L
2025
2024
2023
2022
2021
Revenue
Gross Profit
Earnings Before Interest and Taxes (EBIT)
Net Income
Total Current Assets
Total Assets
Total Liabilities
Net Debt
Total Equity
Cash Flow from Operating
Cash Flow from Investing
Cash Flow from Financing
Free Cash Flow

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More